166 Recruiting Glioblastoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Glioblastoma Studies
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
📍 Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida
View Study & Checklist ➔Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
📍 Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
📍 Col Uni Med Center New York Presby — New York, New York
View Study & Checklist ➔Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
📍 Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔PH Sensitive MRI Based Resections of Glioblastoma
📍 Ronald Reagan Medical Center — Los Angeles, California
View Study & Checklist ➔Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
View Study & Checklist ➔DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
📍 Michigan State University/Sparrow Hospital — East Lansing, Michigan
View Study & Checklist ➔N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
📍 Chan Soon-Shiong Institute for Medicine (CSSIFM) — El Segundo, California
View Study & Checklist ➔Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
📍 University of Alabama at Birmingham, Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Evaluation of the CONVIVO System
📍 Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
View Study & Checklist ➔Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔A Study of Abemaciclib in Recurrent Glioblastoma
📍 University of California Los Angeles — Los Angeles, California
View Study & Checklist ➔Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
📍 West Virginia University Cancer Institute Mary Babb Randolph Cancer Center — Morgantown, West Virginia
View Study & Checklist ➔A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
📍 Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
📍 Northwestern Memorial Hospital — Chicago, Illinois
View Study & Checklist ➔Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
📍 Mays Cancer Center, UT Health San Antonio — San Antonio, Texas
View Study & Checklist ➔Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
📍 HonorHealth Scottsdale Osborn Medical Center — Scottsdale, Arizona
View Study & Checklist ➔A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
📍 University of Florida Health — Gainesville, Florida
View Study & Checklist ➔A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
📍 Department of Radiation Oncology at University of Iowa — Iowa City, Iowa
View Study & Checklist ➔